Does Morton’s Neuroma Go Away on Its Own?

Morton’s neuroma does not typically go away on its own. The condition involves fibrosis, a type of scarring, around a nerve in the ball of the foot, and that structural change does not reverse itself spontaneously. However, the symptoms can be managed well enough that many people avoid surgery, and the degree of relief depends heavily on factors like the size of the neuroma and how long it has been present. The picture is more nuanced than a simple yes or no, because what people often mean by “going away” is really “stopping the pain,” and those are two different things.

What Is Actually Happening in Your Foot

Despite its name, Morton’s neuroma is not a true tumor of the nerve. It is fibrosis, meaning thickened scar-like tissue that forms around one of the small nerves running between your metatarsal bones (the long bones of the forefoot).¹ The condition most commonly affects the nerve between the third and fourth toes, though the second web space is also frequently involved. The taut ligament that runs across the metatarsal heads appears to play a key role, compressing the nerve from above while the ground pushes up from below.²

This matters for the “will it go away” question because fibrosis is fundamentally different from inflammation. An inflamed tendon or a bruised joint can heal and return to normal. Fibrotic tissue, once formed, does not remodel back into healthy nerve tissue on its own. The nerve becomes permanently thickened. That is why removing the mechanical irritation that caused the problem can reduce pain, sometimes dramatically, without actually eliminating the neuroma itself.

Why Symptoms Sometimes Seem to Disappear

Some people do report that their Morton’s neuroma symptoms faded over time without any treatment at all, which understandably creates the impression that the condition resolved. A few things could be happening. First, people often instinctively change their behavior: switching shoes, avoiding activities that provoke the pain, or altering their gait. These changes reduce the mechanical stress on the nerve and can quiet symptoms. Second, a small neuroma that has not yet developed extensive fibrosis may respond well to even modest changes in footwear or activity. The nerve is irritated but not yet structurally locked into a painful state.

But quieting symptoms is not the same as the neuroma disappearing. The thickened tissue is still there, and if you return to the same shoes or activities that triggered the problem, the pain tends to come back. In studies following patients after corticosteroid injections, which are far more targeted than just changing shoes, a meaningful percentage still required surgery down the line for persistent or recurring pain.³ If injections cannot reliably make it go away for good, simply waiting is unlikely to do better.

How Effective Are Conservative Treatments

The first-line approach for Morton’s neuroma is almost always conservative, and for good reason. Changing your footwear and using insoles or metatarsal pads can make a real difference in symptoms. The idea is to spread the load across the forefoot and lift the metatarsal heads slightly apart, reducing the squeeze on the nerve. A randomized controlled trial found that customized insoles with metatarsal and arch support relieved walking pain and improved function compared to a sham insole.⁴

A comparative study at 12 months found that about two-thirds of people treated with footwear modifications alone had complete or partial pain relief, which is encouraging. Steroid injections performed better in the same study, with roughly four in five patients reporting relief.⁵ Physical therapy may also contribute. A case report on a combined physical therapy approach showed improvements in pain, ankle range of motion, and function, though the evidence here is still limited to small studies.⁶

High-heeled shoes deserve a specific mention. Research measuring in-shoe pressure confirms that high heels significantly increase pressure under the metatarsal heads compared to flat shoes or running shoes.⁷ If you regularly wear heels and develop a Morton’s neuroma, switching to shoes with a wider toe box and lower heel may be the single most impactful conservative change you can make.

The Size and Time Window That Predict Your Outcome

Not all Morton’s neuromas respond equally to conservative care, and the research points to two factors that strongly predict whether non-surgical treatment will work: how big the neuroma is and how long you have been dealing with it.

A review of studies on orthotics and shoe modifications found that a threshold of about four and a half months emerges from the data. Beyond that point, and especially in neuromas larger than 5 to 6 mm, these conservative measures stop acting as a real treatment and become more of a way to manage pain and maintain an acceptable quality of life.⁸ Ultrasound research supports this from another angle: roughly 84% of neuromas longer than 6.3 mm did not achieve pain remission after the first round of corticosteroid treatment.⁹ And a prospective study confirmed that the size of the neuroma was the sole significant predictor of whether corticosteroid injections would fail.¹⁰

Interestingly, one study found that younger patients were more likely to need further intervention after corticosteroid injections, alongside those with larger neuromas.¹¹ The reason is not entirely clear, but younger patients may be more active and less willing to accept residual symptoms, or their neuromas may be subjected to greater mechanical stress.

The practical takeaway here is that early intervention matters. A small, recently symptomatic neuroma is far more likely to respond to conservative care than a large, long-standing one. If you have been dealing with forefoot pain for months and haven’t tried anything, you are losing ground.

Corticosteroid Injections and How Long They Last

Corticosteroid injections are one of the most commonly used treatments for Morton’s neuroma, sitting between pure conservative care and surgery. A systematic review found that they provide satisfactory outcomes over 3 to 12 months of follow-up, with the biggest pain reduction happening between one week and three months after the injection. However, about 30% of injected patients eventually ended up needing surgery because the pain came back.³

The longer you follow patients, the less impressive the numbers look. A systematic review of injection therapies noted that most researchers describe the benefit of corticosteroid injections as temporary. Two studies with longer follow-up periods, one at nearly five years and another at three years, found that injections remained effective in only about a third to half of patients.¹² That said, the same review noted that a subset of patients does remain symptom-free long-term, and these favorable outcomes may be more common in neuromas of recent onset, where the fibrosis has not yet become firmly established.

How the injection is delivered also matters. Ultrasound-guided corticosteroid injections provide long-term pain relief in more than three-quarters of patients, significantly outperforming blind injections in both pain reduction and function over follow-up periods as long as three years.¹³ If your doctor is offering injections, asking whether they use ultrasound guidance is a reasonable question.

Alcohol Injections and the Long-Term Durability Problem

Alcohol sclerosing injections take a different approach from corticosteroids. Instead of reducing inflammation, the alcohol is meant to destroy the nerve tissue itself, essentially performing a chemical neurolysis. Early results look impressive: one study of over 100 patients reported that 94% experienced partial or total improvement, with 84% becoming completely pain-free. The median pain score dropped from 8 out of 10 to zero.¹⁴

The five-year follow-up data tell a very different story. In a study tracking 45 patients over five years after alcohol injection, roughly a third had already undergone surgery, another group had symptoms return, and only 29% remained symptom-free. Pain scores and satisfaction deteriorated significantly over that time.¹⁵ This is one of the clearest illustrations of why short-term results can be misleading in Morton’s neuroma. A treatment that looks like a cure at six months may look like a temporary fix at five years.

Shockwave Therapy as an Emerging Option

Extracorporeal shockwave therapy (ESWT), which uses focused pressure waves delivered through the skin, has been gaining interest as a non-invasive treatment. A randomized placebo-controlled trial found evidence that ESWT may reduce pain in patients with Morton’s neuroma.¹⁶ The proposed mechanism involves an initial pain-numbing effect from disrupting nerve endings, followed by tissue repair driven by new blood vessel growth.¹⁷

The evidence is still young compared to the decades of data on injections and surgery. Shockwave therapy is not yet a standard recommendation, but it represents the kind of minimally invasive option that could eventually fill the gap between insoles and injections for patients who want to avoid both steroids and surgery. If it does prove durable, it would be a genuinely useful addition to the treatment ladder.

When Surgery Becomes the Best Option

For neuromas that do not respond to conservative care or injections, surgical excision remains the definitive treatment. The procedure involves removing the affected segment of nerve, and outcomes are generally favorable, with good to excellent results reported in about 80% of patients. However, surgery is not a guarantee, and the reasons it can fall short are worth knowing.

The nerve branches in the foot are more variable than many people assume. Anatomical studies have found that the digital nerves have branching patterns that differ substantially from person to person.¹⁸ These branches can contribute to recurrence after surgery, either because a small branch forms its own painful stump neuroma or because the main nerve was not cut back far enough.¹⁹ In one surgical series, 27 patients needed a second operation for recurrent Morton’s neuroma, with the vast majority of recurrences in the third intermetatarsal space, the same location where primary neuromas are most common.²⁰

Recurrence can also result from an incorrect initial diagnosis, inadequate resection, or pressure on the remaining nerve stump. In patients with recurring symptoms or neuromas in multiple spaces between toes, compression of the nerve at a higher level should be considered.²¹ Surgery works well for most people, but going in with realistic expectations about the 15 to 20% of cases that do not get a fully satisfactory result is important.

The size of the neuroma also influences the surgical approach. A recent comparative study found that for neuromas wider than about 7.4 mm, traditional open excision produced better pain scores, function, and satisfaction than a less invasive technique involving percutaneous ligament release.²² Smaller neuromas may respond to the less invasive procedure, which simply releases the ligament compressing the nerve rather than removing the nerve itself. Once again, size turns out to be a key variable in deciding what will work.

Conditions That Mimic Morton’s Neuroma

One underappreciated aspect of this question is that some people whose “Morton’s neuroma” seems to go away, or refuses to respond to standard treatment, may not have had a Morton’s neuroma in the first place. Several conditions produce similar forefoot pain and can be mistaken for a neuroma.

The most important mimic is a plantar plate injury, a tear in the ligament-like structure on the underside of a toe joint. Plantar plate injuries can create a reactive soft tissue mass called a pseudoneuroma, which shows up on ultrasound as a low-density lump in the space between the metatarsals, looking quite similar to a real Morton’s neuroma. The distinguishing features include the shape and position of the mass: a pseudoneuroma tends to be more elongated with a broad base near the toe joint, whereas a true Morton’s neuroma is more oval and centered between the metatarsal heads.²³ Misdiagnosing a plantar plate tear as a Morton’s neuroma matters because the treatments differ, and treating for the wrong condition can actually worsen toe deformity.

Other sources of central forefoot pain include metatarsophalangeal joint synovitis, stress fractures of the metatarsals, bursitis between the metatarsal heads, and referred pain from conditions higher up in the leg. The physical exam for Morton’s neuroma has variable accuracy. A systematic review found that the sensitivity of Mulder’s sign, the classic squeeze-and-click test, ranged wildly from 29% to 94% across different studies, and even the most specific results provided only weak evidence for confirming or ruling out the diagnosis.²⁴ A simpler clinical maneuver, the thumb-index-finger squeeze test, performed considerably better in one study, achieving 96% sensitivity and 96% accuracy, comparable to ultrasound imaging.²⁵

If you have been told you have a Morton’s neuroma but treatment is not working, it is worth asking whether the diagnosis has been confirmed with imaging, and whether an alternative cause for your pain has been ruled out. An ultrasound can both confirm the neuroma and measure its size, which as discussed above is the strongest predictor of how well non-surgical treatment will work.

What Happens If You Simply Do Nothing

There is surprisingly little formal research on the true natural history of untreated Morton’s neuroma, which is part of why this question is hard to answer definitively. Most studies begin at the point where someone seeks treatment, so the data reflect outcomes of intervention rather than observation. The closest we get to a “doing nothing” baseline is the footwear-modification-only arm of comparative studies, which showed about 63% of patients reporting at least partial relief at one year just from changing shoes.⁵ But even that is not truly “nothing”; switching to wider, flatter shoes is a meaningful intervention that changes the mechanical environment around the nerve.

Doing literally nothing, continuing with the same footwear and activity level that provoked the symptoms, is unlikely to produce improvement. The fibrosis that defines the condition does not spontaneously regress, and the mechanical forces that caused it in the first place continue to act on the nerve. Over time, the neuroma can enlarge, and larger neuromas respond less well to every treatment modality, making eventual treatment harder. The logic of early action is not just about getting relief sooner; it is about treating the neuroma while it is still small enough to respond to non-surgical options. Waiting and hoping is a strategy, but the evidence suggests it is not a good one.